Published in Clin Exp Allergy on September 01, 2000
Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis. Thorax (2006) 0.91
Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1. Gut (2005) 0.86
Expression of COX-1 and COX-2 in a clinical model of acute inflammation. J Pain (2007) 0.85
Reconstituted human upper airway epithelium as 3-d in vitro model for nasal polyposis. PLoS One (2014) 0.78
Association of the -14C/G MET and the -765G/C COX-2 gene polymorphisms with the risk of chronic rhinosinusitis with nasal polyps in a Polish population. DNA Cell Biol (2012) 0.76
Increased cyclooxygenase activity impairs apoptosis of inflammatory neutrophils in mice lacking gelatinase B/matrix metalloproteinase-9. Immunology (2008) 0.76
The COX-2-Selective Antagonist (NS-398) Inhibits Choroidal Neovascularization and Subretinal Fibrosis. PLoS One (2016) 0.75
Differential expression of tumor necrosis factor α, interleukin 1β, nuclear factor κB in nasal mucosa among chronic rhinosinusitis patients with and without polyps. Postepy Dermatol Alergol (2017) 0.75
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. BMJ (2000) 5.43
Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med (1997) 3.80
Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51
A comparison of three scales for assessing social functioning in primary care. Am J Psychiatry (2001) 2.18
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur Respir J (1997) 2.08
EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy (2005) 2.07
Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice. Arch Fam Med (2000) 2.01
Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit Care Med (1999) 1.97
Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother (1999) 1.86
Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax (1991) 1.86
Heart rate and performance parameters in elite cyclists: a longitudinal study. Med Sci Sports Exerc (2000) 1.79
Effects of fish farm loadings on seagrass (Posidonia oceanica) distribution, growth and photosynthesis. Mar Pollut Bull (2001) 1.76
[Fiberoptic bronchoscopy in a respiratory intensive care unit]. Med Intensiva (2011) 1.75
Validation of different techniques for the diagnosis of ventilator-associated pneumonia. Comparison with immediate postmortem pulmonary biopsy. Am J Respir Crit Care Med (1994) 1.74
A survey of the burden of allergic rhinitis in Europe. Allergy (2007) 1.71
Clinical and functional assessment of patients with idiopathic pulmonary fibrosis: results of a 3 year follow-up. Eur Respir J (1994) 1.68
A prospective study of unplanned endotracheal extubation in intensive care unit patients. Crit Care Med (1998) 1.60
Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax (2002) 1.59
Polar targeting of Shigella virulence factor IcsA in Enterobacteriacae and Vibrio. Proc Natl Acad Sci U S A (2001) 1.56
EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy (2007) 1.53
Nuclear factor-kappaB activity is down-regulated in nasal polyps from aspirin-sensitive asthmatics. Allergy (2003) 1.53
Initial studies with high resolution TEM and electron energy loss spectroscopy studies of ferritin cores extracted from brains of patients with progressive supranuclear palsy and Alzheimer disease. Cell Mol Biol (Noisy-le-grand) (2000) 1.51
Feasibility trial of methotrexate-paclitaxel as a second line therapy in advanced urothelial cancer. Cancer Invest (2002) 1.50
Etiology and microbial patterns of pulmonary infiltrates in patients with orthotopic liver transplantation. Chest (2000) 1.49
Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis (2003) 1.46
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. Allergy (2010) 1.45
Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis (1991) 1.44
[Grade of consistency existing in the grade of hepatic fibrosis calculated with the APRI and FORNS biochemistry indexes and transient elastography (Fibroscan in patients coinfected with HIV-HCV]. Rev Clin Esp (2010) 1.44
Apolipoprotein E phenotypes, lipoprotein composition, and xanthelasmas. Arch Dermatol (1988) 1.42
Papules in the auricular concha: lichen amyloidosus in a case of biphasic amyloidosis. Dermatologica (1990) 1.42
A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo. Neurobiol Dis (2009) 1.42
[Effectiveness of postoperative autologous blood transfusion after knee replacement surgery and influence of preoperative hemoglobin level]. Rev Esp Anestesiol Reanim (2005) 1.40
Noninvasive nasal mask ventilation beyond the ICU for an exacerbation of chronic respiratory insufficiency. Chest (1995) 1.40
[On the translation of lobar and lobectomy into Spanish]. Arch Bronconeumol (2005) 1.40
Patients with chronic glucocorticoid treatment develop changes in muscle glycogen metabolism. J Neurol Sci (1993) 1.39
Bronchiolitis obliterans organizing pneumonia. Trying to answer an intriguing question. Respiration (2000) 1.39
[Nonspecific interstitial pneumonia: epidemiologic and clinical characteristics]. Med Clin (Barc) (2006) 1.39
[Labeling of injectable drugs used in anesthesia]. Rev Esp Anestesiol Reanim (2011) 1.39
[Knowledge and attitude regarding previous instructions for the patients of a public hospital of Madrid]. Rev Clin Esp (2011) 1.39
[Acute myopathy related to the administration of glucocorticoids and neuromuscular blockers]. Med Clin (Barc) (1994) 1.38
Bronchial inflammation and colonization in patients with clinically stable bronchiectasis. Am J Respir Crit Care Med (2001) 1.37
Activity of CeOx and TiOx nanoparticles grown on Au(111) in the water-gas shift reaction. Science (2007) 1.33
Mechanical ventilation in severe exacerbation of asthma. Study of 26 cases with six deaths. Eur J Respir Dis (1983) 1.26
Methylmalonic acidaemia: examination of genotype and biochemical data in 32 patients belonging to mut, cblA or cblB complementation group. J Inherit Metab Dis (2007) 1.25
Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy (2010) 1.24
Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia. Am Rev Respir Dis (1989) 1.24
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'. Allergy (2009) 1.22
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax (2003) 1.22
Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B. Org Lett (2000) 1.20
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy (2008) 1.20
Saliva composition and exercise. Sports Med (1998) 1.18
Combined aerobic and resistance training in breast cancer survivors: A randomized, controlled pilot trial. Int J Sports Med (2006) 1.16
Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Thorax (2001) 1.14
Pulmonary complications in patients with haematological malignancies treated at a respiratory ICU. Eur Respir J (1998) 1.14
Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med (1999) 1.13
Rupatadine in allergic rhinitis and chronic urticaria. Allergy (2008) 1.13
Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy (2012) 1.13
Measurement of cell microrheology by magnetic twisting cytometry with frequency domain demodulation. J Appl Physiol (1985) (2001) 1.13
Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. A one-year follow-up study. Am Rev Respir Dis (1990) 1.12
Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. Eur Respir J (1999) 1.12
[The rights of the hospital patient: the knowledge and perception of their fulfillment on the part of the professional. The Group in Catalonia of the Spanish Society of Care for the Health Services User]. Rev Clin Esp (1998) 1.10
Genetic aspects of allergic rhinitis. J Investig Allergol Clin Immunol (2009) 1.10
Air pollution and allergens. J Investig Allergol Clin Immunol (2007) 1.09
Threshold dependence of mortality effects for fine and coarse particles in Phoenix, Arizona. J Air Waste Manag Assoc (2000) 1.09
Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis - a GALEN study. Allergy (2009) 1.08
Nonpuerperal breast infection. Infect Dis Obstet Gynecol (1995) 1.08
CT of pulmonary epithelioid hemangioendothelioma. J Comput Assist Tomogr (1994) 1.08
[Bronchial asthma and bronchial hyperreactivity: friends for ever]. Med Clin (Barc) (1996) 1.07
Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations. FEBS Lett (1999) 1.06
Modulation of the allergic reactivity of slum children by helminthic infection. Parasite Immunol (1993) 1.05
Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy (2006) 1.05
Correlation of bronchoalveolar lavage and clinical and functional findings in asbestosis. Am Rev Respir Dis (1986) 1.05
Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot study. Med Intensiva (2012) 1.05
In vitro development of Staphylococcus aureus biofilms using slime-producing variants and ATP-bioluminescence for automated bacterial quantification. Luminescence (2000) 1.04
Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy (2011) 1.03
Stress and allergy. J Investig Allergol Clin Immunol (2009) 1.03
Functional capacity of children with leukemia. Int J Sports Med (2007) 1.03
Induced sputum in the diagnosis of peripheral lung cancer not visible endoscopically. Respir Med (2001) 1.02
Medically unexplained symptoms in an urban general medicine practice. Psychosomatics (2001) 1.02
Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression. J Immunol (2000) 1.02
Effect of H1 antihistamines upon the central nervous system. J Investig Allergol Clin Immunol (2006) 1.01
Benefits of intrahospital exercise training after pediatric bone marrow transplantation. Int J Sports Med (2007) 1.01
Does an educational leaflet improve self-reported adherence to therapy in osteoporosis? The OPTIMA study. Osteoporos Int (2005) 1.01
Chylothorax and tuberculosis. Thorax (1983) 1.01
Expression of the human glucocorticoid receptor alpha and beta isoforms in human respiratory epithelial cells and their regulation by dexamethasone. Am J Respir Cell Mol Biol (2001) 1.00
Endocrinologic profile of patients with idiopathic melasma. J Invest Dermatol (1983) 1.00
Helminthic infection and anthropometric indicators in children from a tropical slum: Ascaris reinfection after anthelmintic treatment. J Trop Pediatr (1999) 1.00
Ascaris reinfection of slum children: relation with the IgE response. Clin Exp Immunol (1993) 1.00